These effects contrast sharply with the phenotype of highly amplified MYC, which is enriched in metastatic and treatment-resistant prostate cancers, and mirrors the role of MYC in other cancer types via effects on AKT to contribute toward cell division and survival [15–17]. The gene discussed is MYC; the disease is prostate cancer.